Portal de investigación
Plataformas biobancos PT17/0015/0049
Datos básicos
- Protocolo:
- PT17/0015/0049
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL CLINICO UNIVERSITARIO DE VALENCIA
- Año de incio:
- 2018
- Año de finalización:
- 2020
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
INSTITUTO SALUD CARLOS III
Resultados del Ensayo Clínico
Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer.
Nunez-Torres, Rocio; (...); Gonzalez-Neira, Anna
Article. 10.1001/jamadermatol.2020.1867. 2020
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences.
Henriksen, Tenna Vesterman; (...); Andersen, Claus Lindbjerg
Article. 10.1158/1078-0432.CCR-21-2404. 2022
High numbers of circulating CD57+ NK cells associate with resistance to HER2-specific therapeutic antibodies in HER2+ primary breast cancer.
Muntasell, Aura; (...); Lopez-Botet, Miguel
Article. 10.1158/2326-6066.CIR-18-0896. 2019
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma.
Cabeza-Segura, M; (...); Fleitas, T
Article. 10.1038/s41416-022-02005-z. 2022
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.
Gambardella, Valentina; (...); Roda, Desamparados
Article. 10.1038/s41416-021-01502-x. 2021
